Publication | Closed Access
How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
21
Citations
6
References
2020
Year
Independent Cancer DrugsJacoline BouvyMedicineCancer ManagementPathologyOutcomes ResearchSophie CooperPharmacoeconomicsCost EffectivenessAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer EducationCancer Research
Sophie Cooper, Jacoline Bouvy and colleagues discuss the challenges that histology independent cancer drugs will pose for NICE and the NHS
| Year | Citations | |
|---|---|---|
Page 1
Page 1